No Picture
News

Lineage Cell Therapeutics to Apply Allogeneic Dendritic Cell Therapy Program to COVID-19 Vaccine Development

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #COVID19–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it has applied fo… […]

No Picture
News

Lineage Cell Therapeutics to Apply Allogeneic Dendritic Cell Therapy Program to COVID-19 Vaccine Development

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #COVID19–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it has applied fo… […]

No Picture
News

Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials

SAN DIEGO, May 5, 2020 /PRNewswire/ –?Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agr… […]

No Picture
News

DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors

Phase 2 trial more than 90% enrolled with enrollment continuing even in light of coronavirus pandemic

SAN DIEGO, May 5, 2020 /PRNewswire/ –?DelMar Pharmaceuticals, Inc.?(Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused … […]

No Picture
News

A UCSD center that’s been facilitating Covid-19 clinical research gets $55M from NIH to boost translational work

A team at the University of California San Diego that?s been facilitating studies on the frontlines of Covid-19 has received a $54.7 million grant from the NIH to bind basic research with clinical care even more tightly together.
Every year the 1,000 f… […]